Denosumab-Teva onco
Denosumab-Teva onco is a biosimilar from Teva Pharma AG and is listed on the FOPH Specialities List. As the follow-on product of a biologic it is reimbursed by basic health insurance. The public price ranges from CHF 210.45 to CHF 210.45 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Teva Pharma AG
- ATC code
- M05BX04
- IT group
- 07.16.10 Cytostatica
- Active substances
- Denosumabum
- Preparation type
- Biosimilar
- On the SL since
- 01/03/2026
- Last price change
- 01/04/2026
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 120 mg/1.7 ml | Durchstf 1.7 ml | CHF 172.04 | CHF 210.45 | 01/03/2026 | A | 7680701320015 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Vergütung bei Erwachsenen und Jugendlichen mit abgeschlossener Skelettreifung mit Riesenzelltumoren des Knochens, die entweder nicht resezierbar sind oder bei denen eine Resektion wahrscheinlich zu hoher Morbidität führen würde.
More preparations in this group
FAQ
Is Denosumab-Teva onco covered by Swiss health insurance?
Yes, but only under conditions. Denosumab-Teva onco is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Denosumab-Teva onco cost in Switzerland?
The public price is the maximum price set by the FOPH and for Denosumab-Teva onco ranges from CHF 210.45 to CHF 210.45 per pack. The ex-factory price ranges from CHF 172.04 to CHF 172.04. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages